뉴스벤징가
Scholar Rock Marks 'Defining Moment' with First Muscle-Targeted Treatment for Spinal Muscular Atrophy
· 발표
기사 요약
FDA approves Scholar Rock Isembyld to treat spinal muscular atrophy in adults and pediatric patients two years and older.
기사 원문에서 발췌했어요.
댓글 —
댓글을 불러오고 있어요…